Lymphodepleting chemotherapy practices and effect on safety and efficacy outcomes in patients with solid tumours undergoing T cell receptor-engineered T cell (TCR-T) Therapy: a systematic review and meta-analysis

BACKGROUND: T cell receptor-engineered T cell (TCR-T) therapy has shown promising efficacy in advanced solid tumours. Lymphodepleting (LD) chemotherapy improves TCR-T cell therapy efficacy but is associated with significant toxicities. Evidence is sparse regarding the optimum LD regimen for TCR-T ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Owen, Kathryn, Ghaly, Ramy, Shohdy, Kyrillus S., Thistlethwaite, Fiona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628360/
https://www.ncbi.nlm.nih.gov/pubmed/36315268
http://dx.doi.org/10.1007/s00262-022-03287-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628360/
https://www.ncbi.nlm.nih.gov/pubmed/36315268
http://dx.doi.org/10.1007/s00262-022-03287-1

Ejemplares similares